MHMelissa M. Harrison

Melissa M. Harrison

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melissa M. Harrison has a total of 172 co-authors. Here are the top co-authors by number of shared publications:

  • Tyler J. Gibson

    Department of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA

    7 shared publications
  • Tyler J. Gibson

    Section of Developmental Biology, Department of Pediatrics, School of Medicine, University of Colorado Anschutz (Aurora, CO, USA)

    7 shared publications
  • Cheng-Yu Lee

    Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Division of Genetic Medicine, Department of Internal Medicine and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA

    6 shared publications
  • Elizabeth D. Larson

    Department of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706

    6 shared publications
  • Hideyuki Komori

    Life Sciences Institute, University of Michigan, Ann Arbor, MI

    5 shared publications
  • Peter W. Lewis

    Department of Biomolecular Chemistry, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53706, USA

    5 shared publications

Latest Publications

  • Open Access

    Programmed ribosomal frameshifting regulates tissue-specific pioneer activity

    by Eliana F. Torres-Zelada, Hideyuki Komori, Marcel Morgenstern, Benjamin Chadwick, Hsiao-Yun Liu, Elizabeth D. Larson, Ally W.H. Yang, Timothy R. Hughes, Andrew A. Mehle, Joshua J Coon, et al.

    Pioneer transcription factors bind nucleosomal DNA and establish accessible chromatin, yet their binding is tissue specific 1–5 . While studies have largely focused on protein-extrinsic features, like chromatin structure and cofactor expression, the mechanisms governing the tissue-specific binding remain poorly understood. We used the Drosophila pioneer transcription factor Zelda as a paradigm to investigate the mechanisms controlling tissue-specific binding. Zelda promotes the undifferentiated state in both the embryo and in neural stem cells of the larval brain 6–10 . However, Zelda binds thousands of unique sites in each tissue and, in so doing, defines tissue-specific enhancers 6 . We showed that tissue-specific binding is controlled by the developmentally regulated use of two distinct DNA-binding domains. Our identification of a novel, neural stem cell enriched Zelda proteoform that lacks the embryo-specific C-terminal DNA-binding domain explains the differential DNA-binding domain usage. This proteoform arises through developmentally regulated −1 ribosomal frameshifting, a mechanism common to viruses but not documented for any eukaryotic transcription factors. Together we revealed a new strategy where developmentally programmed ribosomal frameshifting confers tissue-specific pioneer-factor binding and suggest that this mechanism may be more broadly used to diversify the proteome than previously appreciated.

  • Open Access

    Pioneer-factor activity requires stable chromatin occupancy mediated by both sequence-specific binding and disordered protein domains

    by Meghan M. Freund, F. Javier Deharo-Arbona, Sarah Baloul, Ali Torhorst, Charalambos Roussos, Abby J. Ruffridge, Andrew Q. Rashoff, Ryen Hazzard, Peter W. Lewis, Sarah J. Bray, et al.

    Pioneer transcription factors overcome the restrictive barrier imposed by chromatin to drive cell-fate specification, yet how their domains collectively support this activity remains unclear. Here, we use the deeply conserved pioneer factor Grainy head to define the protein-intrinsic features that govern pioneering activity. By integrating biochemistry, genomics, and quantitative live-cell imaging, we determined that both the conserved DNA-binding domain and the extended, intrinsically disordered N terminus are required for the stable chromatin occupancy that supports access to closed chromatin and the induction of chromatin accessibility. The disordered N terminus supports pioneer activity through interactions that do not rely on strict amino acid sequence but instead on overall composition. While our results show that pioneering activity depends on the combinatorial contributions of structured and disordered domains, mitotic retention depends solely on sequence-specific DNA binding. These results support stable chromatin occupancy mediated by multiple protein domains as necessary for pioneering function and that this is separable from the mechanisms required for mitotic retention.


  • Open Access

    Three-dimensional genome reorganization foreshadows zygotic genome activation in Drosophila

    by Noura Maziak, Yuchen Zhang, Fabian Groll, Haley E. Brown, Alla Madich, Yadwinder Kaur, Melissa M. Harrison, Jian Zhou, Juan M. Vaquerizas

    How chromatin conformation relates to chromatin state remains a central challenge in genome regulation. Here we present Pico-C, a low-input Micro-C approach that enables high-resolution, temporally resolved three-dimensional genome mapping during early Drosophila embryogenesis. Contrary to a prevailing view of a disorganized genome before zygotic genome activation (ZGA), we uncover a dynamic and ordered emergence of chromatin loops during pre-ZGA nuclear cycles. Spatial autocorrelation analysis points to context-dependent regulatory influences on chromatin. Notably, inhibition of transcriptional elongation has site-specific effects, retaining some early loops while weakening insulation at active promoters, suggesting distinct regulatory dependencies. Machine learning models trained on sequence features identify orthogonal, motif-specific contributions to architecture. Co-depletion of the pioneer factors Zelda and GAF leads to factor-specific perturbations in chromatin architecture, further highlighting a modular regulatory logic in genome establishment. Together, our findings reveal that early genome organization is orchestrated by an interplay of overlapping yet separable regulatory inputs.


  • Open Access

    Pioneer-factor activity requires stable chromatin occupancy mediated by both sequence-specific binding and disordered protein domains

    by Meghan M. Freund, F. Javier Deharo-Arbona, Sarah Baloul, Ali Torhorst, Charalambos Roussos, Abby J. Ruffridge, Andrew Q. Rashoff, Ryen Hazzard, Peter W. Lewis, Sarah J. Bray, et al.

    Pioneer transcription factors overcome the restrictive barrier imposed by chromatin to drive cell-fate specification, yet how their domains collectively support this activity remains unclear. Here, we use the deeply conserved pioneer factor Grainy head to define the protein-intrinsic features that govern pioneering activity. By integrating biochemistry, genomics and quantitative live-cell imaging, we determined that both the conserved DNA-binding domain and the extended, intrinsically disordered N-terminus are required for the stable chromatin occupancy that supports access to closed chromatin and the induction of chromatin accessibility. The disordered N-terminus supports pioneer activity through interactions that do not rely on strict amino acid sequence but instead overall composition. While our results show that pioneering activity depends on the combinatorial contributions of structured and disordered domains, mitotic retention depends solely on sequence-specific DNA binding. These results support stable chromatin occupancy mediated by multiple protein domains as necessary for pioneering function and that this is separable from the mechanisms required for mitotic retention.


  • Open Access

    Differential usage of two, distinct DNA-binding domains regulates tissue-specific occupancy of the pioneer factor Zelda

    by Eliana F. Torres-Zelada, Hideyuki Komori, Hsiao-Yun Liu, Elizabeth D. Larson, Ally W.H. Yang, Zoe A. Fitzpatrick, Timothy R. Hughes, Christine A. Rushlow, Cheng-Yu Lee, Melissa M. Harrison

    Pioneer transcription factors act at the top of gene-regulatory networks by promoting accessible chromatin at the cis -regulatory regions that drive gene expression. Despite their ability to bind closed chromatin, pioneer factors occupy distinct binding sites in different tissues. The pioneer factor Zelda promotes the undifferentiated fate in both the early Drosophila embryo and in the neural stem cells (neuroblasts) of the larval brain. Tissue-specific binding by Zelda identifies cell-type specific enhancers, which are enriched for different DNA-sequence motifs. We investigated the features that promoted cell-type specific occupancy by testing the role of conserved, structured protein domains in the capacity of Zelda to promote the embryonic and neuroblast cell fates. We unexpectedly identified that the most deeply conserved region in Zelda, the second zinc finger, has opposing functions in the embryo and neuroblasts. We showed that this zinc finger is a previously unrecognized DNA-binding domain that is specifically required for Zelda binding to a G-rich motif in larval neuroblasts. The pioneering function of Zelda depends largely on the C-terminal cluster of zinc fingers that promotes binding in the early embryo, suggesting that pioneer function may depend on how Zelda engages the genome. As opposed to co-factor expression or chromatin environment, our data identify tissue-specific usage of two, widely separated DNA-binding domains as the mechanism controlling tissue-specific binding and activity.


  • Novel modifiers of oncoprotein-mediated Polycomb inhibition in Drosophila melanogaster

    by Samuel D Krabbenhoft, Tyler E Masuda, Yadwinder Kaur, Truman J Do, Siddhant U Jain, Peter W Lewis, Melissa M Harrison

    Polycomb Repressive Complex 2 (PRC2) maintains epigenetic repression through the catalysis of H3K27 trimethylation (H3K27me3), which restricts gene expression and preserves developmental gene-regulatory networks. The integrity of PRC2-mediated gene silencing depends critically on the ability of PRC2 to establish and propagate H3K27me3 beyond initial recruitment sites. The oncoproteins EZHIP and histone H3 K27M specifically inhibit this propagation by blocking the allosterically activated state of PRC2, leading to global disruption of H3K27me3 patterns and developmental abnormalities. To uncover chromatin-related pathways intersecting with PRC2 repression, we developed a Drosophila melanogaster model with tissue-specific expression of EZHIP and H3 K27M. A targeted RNAi screen of conserved chromatin regulators identified genetic modifiers that when knocked down either enhanced or suppressed developmental phenotypes driven by these PRC2 inhibitors. Strong suppressors, including the Trithorax group proteins Ash1 and Trx, the PR-DUB complex member Asx, and the nucleoporin Nup153, restored normal development despite persistent depletion of global H3K27me3. Gene expression analyses revealed that suppression reflected reduced expression of genes aberrantly activated following PRC2 inhibition. Together, these findings highlight conserved chromatin-regulatory pathways that intersect with Polycomb to maintain transcriptional balance and support developmental homeostasis.


  • Catalytic-dependent and independent functions of the histone acetyltransferase CBP promote pioneer-factor-mediated zygotic genome activation

    by Audrey J. Marsh, Sergei Pirogov, Yadwinder Kaur, Abby J. Ruffridge, Suresh Sajwan, Tyler J. Gibson, George Hunt, Melissa M. Harrison, Mattias Mannervik


  • Open Access

    Investigating oncoprotein-mediated chromatin dysregulation in Drosophila melanogaster uncovers novel modifiers of the developmental impact of H3 K27M and EZHIP

    by Samuel D. Krabbenhoft, Tyler E Masuda, Yadwinder Kaur, Truman J. Do, Siddhant U. Jain, Peter W. Lewis, Melissa M. Harrison

    Polycomb Repressive Complex 2 (PRC2) maintains epigenetic repression through the catalysis of H3K27 trimethylation (H3K27me3), which restricts gene expression and preserves developmental gene-regulatory networks. The integrity of PRC2-mediated gene silencing depends critically on the ability of PRC2 to establish and propagate H3K27me3 beyond initial recruitment sites. The oncoproteins EZHIP and histone H3 K27M specifically inhibit this propagation by blocking the allosterically activated state of PRC2, leading to global disruption of H3K27me3 patterns and developmental abnormalities. To uncover chromatin-related pathways intersecting with PRC2 repression, we developed a Drosophila melanogaster model with tissue-specific expression of EZHIP and H3 K27M. A targeted RNAi screen of conserved chromatin regulators identified genetic modifiers that when knocked down either enhanced or suppressed developmental phenotypes driven by these PRC2 inhibitors. Strong suppressors, including the Trithorax-group proteins Ash1 and Trx, the PR-DUB complex member Asx, and the nucleoporin Nup153, restored normal development despite persistent depletion of global H3K27me3. Gene expression analyses revealed that suppression reflected reduced expression of genes aberrantly activated following PRC2 inhibition. Together, these findings highlight conserved chromatin-regulatory pathways that intersect with Polycomb to maintain transcriptional balance and support developmental homeostasis.

  • Open Access

    Catalytic-dependent and independent functions of the histone acetyltransferase CBP promote pioneer factor-mediated zygotic genome activation

    by Audrey J. Marsh, Sergei Pirogov, Abby J. Ruffridge, Suresh Sajwan, Tyler J. Gibson, George Hunt, Yadwinder Kaur, Melissa M. Harrison, Mattias Mannervik

    Summary: Immediately after fertilization the genome is transcriptionally quiescent. Maternally encoded pioneer transcription factors reprogram the chromatin state and facilitate the transcription of the zygotic genome. In Drosophila , transcription is initiated by the pioneer factor Zelda. While Zelda-occupied sites are enriched with histone acetylation, a post-translational mark associated with active cis -regulatory regions, the functional relationship between Zelda and histone acetylation in zygotic genome activation remained unclear. We show that Zelda-mediated recruitment of the histone acetyltransferase CBP is essential for zygotic transcription. CBP catalytic activity is necessary for release of RNA Polymerase II (Pol II) into transcription elongation and for embryonic development. However, CBP also activates zygotic transcription independent of acetylation through Pol II recruitment. Neither acetylation nor CBP are required for the pioneering function of Zelda. Our data suggest that pioneer factor-mediated recruitment of CBP is a conserved mechanism required to activate zygotic transcription but that this role is separable from the function of pioneer factors in restructuring chromatin accessibility.


  • Exploring the reciprocity between pioneer factors and development

    by Meghan M. Freund, Melissa M. Harrison, Eliana F. Torres-Zelada

    Development is regulated by coordinated changes in gene expression. Control of these changes in expression is largely governed by the binding of transcription factors to specific regulatory elements. However, the packaging of DNA into chromatin prevents the binding of many transcription factors. Pioneer factors overcome this barrier owing to unique properties that enable them to bind closed chromatin, promote accessibility and, in so doing, mediate binding of additional factors that activate gene expression. Because of these properties, pioneer factors act at the top of gene-regulatory networks and drive developmental transitions. Despite the ability to bind target motifs in closed chromatin, pioneer factors have cell type-specific chromatin occupancy and activity. Thus, developmental context clearly shapes pioneer-factor function. Here, we discuss this reciprocal interplay between pioneer factors and development: how pioneer factors control changes in cell fate and how cellular environment influences pioneer-factor binding and activity.